Channel Sponsor - Turnaround

Sponsored by ASCOA | | (866) 982-7262

Surgery Partners outlook, USPI leadership move & more – 5 recent key notes on ASC companies

Here are five recent news updates on ambulatory surgery center companies.

The $792 million Surgery Partners and Symbion deal is expected to close in the fourth quarter of this year. Moody's Investors Services gave Surgery Partners a 'B3' rating. Moody's attributed its rating to the company's high level of debt, but offered a positive outlook on the company's place in a growing industry. Standard & Poor's Ratings Service predicts moderate cash flow and stable margins, but mentioned the risk of integration on such a large scale.

In the closing of the $2.35 billion Sheridan Healthcare acquisition, AmSurg paid approximately $2.1 billion in cash and issued 5.7 million shares of common stock.  

Harold L. Paz, MD, a United Surgical Partners International board member, will join Aetna as executive vice president and chief medical officer.

Hospital Corporation of America stock traded at $62.44 per share during the week of July 14 to 18, up 11.62 percent.

Medical Facilities Corporation announced a cash pay dividend of $Cdn$0.09375 per common share, while will be payable on August 15.

If you have a question, issue or note to suggest on an ASC management and development company please contact Carrie Pallardy at or Laura Dyrda at

More Articles on ASC Issues:
9 ASC Joint Venture Operating Agreement Issues That Make or Break the Partnership
6 Recent GI Field Partnerships
6 Must-Reads for ASC Turnaround Success

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months